AMN's Aroon Indicator triggered a bullish signal on November 02, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 162 similar instances where the Aroon Indicator showed a similar pattern. In 133 of the 162 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 82%.
Following a +0.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMN advanced for three days, in 222 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The 10-day RSI Indicator for AMN moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 20 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 51 of 65 cases where AMN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
AMN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.391) is normal, around the industry mean (204.027). P/E Ratio (16.827) is within average values for comparable stocks, (19.383). Projected Growth (PEG Ratio) (1.159) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.092) among similar stocks. P/S Ratio (0.397) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
ENSG moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend. In 33 of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on ENSG as a result. In 59 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for ENSG just turned positive on October 28, 2026. Looking at past instances where ENSG's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
The 10-day moving average for ENSG crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.
Following a +9.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENSG advanced for three days, in 196 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENSG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
ENSG broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 29 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. ENSG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.274) is normal, around the industry mean (204.027). P/E Ratio (27.254) is within average values for comparable stocks, (19.383). Projected Growth (PEG Ratio) (1.391) is also within normal values, averaging (2.498). Dividend Yield (0.001) settles around the average of (0.092) among similar stocks. P/S Ratio (1.925) is also within normal values, averaging (2.688).
AMN | ENSG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 41 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 79 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 29 | |
SMR RATING 1..100 | 54 | 52 | |
PRICE GROWTH RATING 1..100 | 34 | 49 | |
P/E GROWTH RATING 1..100 | 13 | 69 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMN's Valuation (70) in the Personnel Services industry is in the same range as ENSG (79) in the Medical Or Nursing Services industry. This means that AMN’s stock grew similarly to ENSG’s over the last 12 months.
ENSG's Profit vs Risk Rating (29) in the Medical Or Nursing Services industry is significantly better than the same rating for AMN (100) in the Personnel Services industry. This means that ENSG’s stock grew significantly faster than AMN’s over the last 12 months.
ENSG's SMR Rating (52) in the Medical Or Nursing Services industry is in the same range as AMN (54) in the Personnel Services industry. This means that ENSG’s stock grew similarly to AMN’s over the last 12 months.
AMN's Price Growth Rating (34) in the Personnel Services industry is in the same range as ENSG (49) in the Medical Or Nursing Services industry. This means that AMN’s stock grew similarly to ENSG’s over the last 12 months.
AMN's P/E Growth Rating (13) in the Personnel Services industry is somewhat better than the same rating for ENSG (69) in the Medical Or Nursing Services industry. This means that AMN’s stock grew somewhat faster than ENSG’s over the last 12 months.
| AMN | ENSG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | N/A |
| Stochastic ODDS (%) | 2 days ago 78% | 2 days ago 63% |
| Momentum ODDS (%) | N/A | 2 days ago 64% |
| MACD ODDS (%) | N/A | 2 days ago 69% |
| TrendWeek ODDS (%) | 2 days ago 77% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 65% |
| Advances ODDS (%) | 5 days ago 74% | 6 days ago 66% |
| Declines ODDS (%) | 7 days ago 79% | 2 days ago 54% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 60% |
| Aroon ODDS (%) | 2 days ago 82% | N/A |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMN’s FA Score shows that 1 FA rating(s) are green while ENSG’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMN’s TA Score shows that 2 TA indicator(s) are bullish while ENSG’s TA Score has 5 bullish TA indicator(s).
AMN (@Hospital/Nursing Management) experienced а -6.59% price change this week, while ENSG (@Hospital/Nursing Management) price change was +1.21% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.38%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +12.65%.
AMN is expected to report earnings on Nov 05, 2026.
ENSG is expected to report earnings on Feb 10, 2027.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor tells us that AMN and CON have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMN and CON's prices will move in lockstep.
| Ticker / NAME | Correlation To AMN | 1D Price Change % | ||
|---|---|---|---|---|
| AMN | 100% | -2.84% | ||
| CON - AMN | 30% Poorly correlated | -0.12% | ||
| USPH - AMN | 30% Poorly correlated | -1.08% | ||
| JYNT - AMN | 27% Poorly correlated | +4.13% | ||
| AAC - AMN | 27% Poorly correlated | N/A | ||
| ASTH - AMN | 24% Poorly correlated | +0.96% | ||
More | ||||
A.I.dvisor indicates that over the last year, ENSG has been loosely correlated with EHC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSG jumps, then EHC could also see price increases.
| Ticker / NAME | Correlation To ENSG | 1D Price Change % | ||
|---|---|---|---|---|
| ENSG | 100% | -1.36% | ||
| EHC - ENSG | 42% Loosely correlated | +0.95% | ||
| HCA - ENSG | 42% Loosely correlated | -1.15% | ||
| PNTG - ENSG | 41% Loosely correlated | -2.78% | ||
| ADUS - ENSG | 35% Loosely correlated | +0.17% | ||
| CHE - ENSG | 32% Poorly correlated | +1.40% | ||
More | ||||